{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:40:30Z","timestamp":1794948030161,"version":"4.9.1"},"reference-count":87,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MH CZ\u2013DRO"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"North American Society of Pediatric Gastroenterology Hepatology and Nutrition Young Investigator Award\/Nestle Nutrition Award"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>A subset of patients with non-alcoholic fatty liver disease develop an inflammatory condition, termed non-alcoholic steatohepatitis (NASH). NASH is characterised by hepatocellular injury, innate immune cell-mediated inflammation and progressive liver fibrosis. The mechanisms whereby hepatic inflammation occurs in NASH remain incompletely understood, but appear to be linked to the proinflammatory microenvironment created by toxic lipid-induced hepatocyte injury, termed lipotoxicity. In this review, we discuss the signalling pathways induced by sublethal hepatocyte lipid overload that contribute to the pathogenesis of NASH. Furthermore, we will review the role of proinflammatory, proangiogenic and profibrotic hepatocyte-derived extracellular vesicles as disease biomarkers and pathogenic mediators during lipotoxicity. We also review the potential therapeutic strategies to block the feed-forward loop between sublethal hepatocyte injury and liver inflammation.<\/jats:p>","DOI":"10.1136\/gutjnl-2017-315691","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T17:15:33Z","timestamp":1516814133000},"page":"963-972","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":265,"title":["Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation"],"prefix":"10.1136","volume":"67","clinical-trial-number":[{"clinical-trial-number":"nct02686762","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02421094","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02442687","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Samar H","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hirsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"2020050721285052000_67.5.963.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2020050721285052000_67.5.963.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.066"},{"key":"2020050721285052000_67.5.963.3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"2020050721285052000_67.5.963.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.07.029"},{"key":"2020050721285052000_67.5.963.5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/538019"},{"key":"2020050721285052000_67.5.963.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5370"},{"key":"2020050721285052000_67.5.963.7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmgh.2014.11.005","article-title":"Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis","volume":"1","author":"Hirsova","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2020050721285052000_67.5.963.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02248.x"},{"key":"2020050721285052000_67.5.963.9","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R066357"},{"key":"2020050721285052000_67.5.963.10","unstructured":"Hirsova P , Ibrahim SH , Malhi H , et al . Hepatocyte lethal and nonlethal lipotoxic injury. In: Ding WX , Yin XM , eds. Cellular injury in liver diseases. 1st ed: Springer International Publishing, 2017."},{"key":"2020050721285052000_67.5.963.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.037"},{"key":"2020050721285052000_67.5.963.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28252"},{"key":"2020050721285052000_67.5.963.13","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M063412"},{"key":"2020050721285052000_67.5.963.14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep4.1069","article-title":"TRAIL deletion prevents liver, but not adipose tissue, inflammation during murine diet-induced obesity","volume":"1","author":"Hirsova","year":"2017","journal-title":"Hepatol Commun"},{"key":"2020050721285052000_67.5.963.15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"2020050721285052000_67.5.963.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27279"},{"key":"2020050721285052000_67.5.963.17","doi-asserted-by":"publisher","DOI":"10.1002\/path.2888"},{"key":"2020050721285052000_67.5.963.18","doi-asserted-by":"crossref","unstructured":"Machado MV , Diehl AM . Hedgehog signalling in liver pathophysiology. J Hepatol 2017.doi:10.1016\/j.jhep.2017.10.017","DOI":"10.1016\/j.jhep.2017.10.017"},{"key":"2020050721285052000_67.5.963.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.10.033"},{"key":"2020050721285052000_67.5.963.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.05.011"},{"key":"2020050721285052000_67.5.963.21","doi-asserted-by":"crossref","unstructured":"Hirsova P , Ibrahim SH , Bronk SF , et al . Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One 2013;8:e70599.doi:10.1371\/journal.pone.0070599","DOI":"10.1371\/journal.pone.0070599"},{"key":"2020050721285052000_67.5.963.22","doi-asserted-by":"crossref","unstructured":"Kwon H , Song K , Han C , et al . Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology 2016;63.doi:10.1002\/hep.28289","DOI":"10.1002\/hep.28289"},{"key":"2020050721285052000_67.5.963.23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25559"},{"key":"2020050721285052000_67.5.963.24","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32674"},{"key":"2020050721285052000_67.5.963.25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5834"},{"key":"2020050721285052000_67.5.963.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.006"},{"key":"2020050721285052000_67.5.963.27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf3934"},{"key":"2020050721285052000_67.5.963.28","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/hep.28814","article-title":"Extracellular vesicles in liver pathobiology: small particles with big impact","volume":"64","author":"Hirsova","year":"2016","journal-title":"Hepatology"},{"key":"2020050721285052000_67.5.963.29","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201504136"},{"key":"2020050721285052000_67.5.963.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.02.010"},{"key":"2020050721285052000_67.5.963.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2016.11.003"},{"key":"2020050721285052000_67.5.963.32","doi-asserted-by":"crossref","unstructured":"Povero D , Eguchi A , Li H , et al . Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One 2014;9:e113651.doi:10.1371\/journal.pone.0113651","DOI":"10.1371\/journal.pone.0113651"},{"key":"2020050721285052000_67.5.963.33","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201211138"},{"key":"2020050721285052000_67.5.963.34","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004512"},{"key":"2020050721285052000_67.5.963.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23148"},{"key":"2020050721285052000_67.5.963.36","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/jcb.25973","article-title":"Mixed lineage kinase 3 mediates the induction of CXCL10 by a STAT1-dependent mechanism during hepatocyte lipotoxicity","volume":"118","author":"Tomita","year":"2017","journal-title":"J Cell Biochem"},{"key":"2020050721285052000_67.5.963.37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00145.2011"},{"key":"2020050721285052000_67.5.963.38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00222.2016"},{"key":"2020050721285052000_67.5.963.39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-\u03b3","volume":"1","author":"Povero","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2020050721285052000_67.5.963.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83885"},{"key":"2020050721285052000_67.5.963.41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R114.619304"},{"key":"2020050721285052000_67.5.963.42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.031"},{"key":"2020050721285052000_67.5.963.43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/pros.23393","article-title":"Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples","volume":"77","author":"Brett","year":"2017","journal-title":"Prostate"},{"key":"2020050721285052000_67.5.963.44","doi-asserted-by":"crossref","first-page":"0021","DOI":"10.1038\/s41551-016-0021","article-title":"Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring","volume":"1","author":"Liang","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"2020050721285052000_67.5.963.45","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201696003"},{"key":"2020050721285052000_67.5.963.46","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.09.008"},{"key":"2020050721285052000_67.5.963.47","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.200"},{"key":"2020050721285052000_67.5.963.48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"2020050721285052000_67.5.963.49","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.19"},{"key":"2020050721285052000_67.5.963.50","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.D029546"},{"key":"2020050721285052000_67.5.963.51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24552"},{"key":"2020050721285052000_67.5.963.52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4878"},{"key":"2020050721285052000_67.5.963.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.04.019"},{"key":"2020050721285052000_67.5.963.54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.03.052"},{"key":"2020050721285052000_67.5.963.55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23253"},{"key":"2020050721285052000_67.5.963.56","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.4254\/wjh.v7.i13.1725","article-title":"Is there a role for adaptive immunity in nonalcoholic steatohepatitis?","volume":"7","author":"Sutti","year":"2015","journal-title":"World J Hepatol"},{"key":"2020050721285052000_67.5.963.57","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.11"},{"key":"2020050721285052000_67.5.963.58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/cphy.c120026","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr Physiol"},{"key":"2020050721285052000_67.5.963.59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10321"},{"key":"2020050721285052000_67.5.963.60","doi-asserted-by":"crossref","unstructured":"Itoh M , Suganami T , Kato H , et al . CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis. JCI Insight 2017;2.doi:10.1172\/jci.insight.92902","DOI":"10.1172\/jci.insight.92902"},{"key":"2020050721285052000_67.5.963.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.01.025"},{"key":"2020050721285052000_67.5.963.62","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50472"},{"key":"2020050721285052000_67.5.963.63","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00365.2011"},{"key":"2020050721285052000_67.5.963.64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.417014"},{"key":"2020050721285052000_67.5.963.65","doi-asserted-by":"crossref","first-page":"28786","DOI":"10.1038\/srep28786","article-title":"CXCL10-mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis","volume":"6","author":"Tomita","year":"2016","journal-title":"Sci Rep"},{"key":"2020050721285052000_67.5.963.66","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J Hepatol"},{"key":"2020050721285052000_67.5.963.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.008"},{"key":"2020050721285052000_67.5.963.68","doi-asserted-by":"crossref","unstructured":"Greuter T , Malhi H , Gores GJ , et al . Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2017;2.doi:10.1172\/jci.insight.95354","DOI":"10.1172\/jci.insight.95354"},{"key":"2020050721285052000_67.5.963.69","doi-asserted-by":"crossref","unstructured":"Rensen SS , Bieghs V , Xanthoulea S , et al . Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS One 2012;7:e52411.doi:10.1371\/journal.pone.0052411","DOI":"10.1371\/journal.pone.0052411"},{"key":"2020050721285052000_67.5.963.70","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2885"},{"key":"2020050721285052000_67.5.963.71","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4294"},{"key":"2020050721285052000_67.5.963.72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312431"},{"key":"2020050721285052000_67.5.963.73","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i19.2184"},{"key":"2020050721285052000_67.5.963.74","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12570"},{"key":"2020050721285052000_67.5.963.75","doi-asserted-by":"crossref","unstructured":"Loomba R , Lawitz E , Mantry PS , et al . The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial. Hepatology 2017.doi:10.1002\/hep.29514","DOI":"10.1002\/hep.29514"},{"key":"2020050721285052000_67.5.963.76","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1016\/S0168-8278(15)30191-4","article-title":"LP37: a placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases","volume":"62","author":"Shiffman","year":"2015","journal-title":"J Hepatol"},{"key":"2020050721285052000_67.5.963.77","first-page":"221","article-title":"Anti-fibrotic and anti-inflammatory activity of the dual CCR2 and CCR5 antagonist cenicriviroc in a mouse model of NASH","volume":"58","author":"Lefebvre","year":"2013","journal-title":"Hepatology"},{"key":"2020050721285052000_67.5.963.78","doi-asserted-by":"crossref","unstructured":"Friedman SL , Ratziu V , Harrison SA , et al . A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology 2017.doi:10.1002\/hep.29477","DOI":"10.1002\/hep.29477"},{"key":"2020050721285052000_67.5.963.79","doi-asserted-by":"crossref","unstructured":"Tomita K , Kohli R , MacLaurin BL , et al . Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis. JCI Insight 2017;2.doi:10.1172\/jci.insight.94488","DOI":"10.1172\/jci.insight.94488"},{"key":"2020050721285052000_67.5.963.80","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303424"},{"key":"2020050721285052000_67.5.963.81","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000229218.97976.43"},{"key":"2020050721285052000_67.5.963.82","doi-asserted-by":"crossref","unstructured":"Traber PG , Zomer E . Therapy of experimental NASH and fibrosis with galectin inhibitors. PLoS One 2013;8:e83481.doi:10.1371\/journal.pone.0083481","DOI":"10.1371\/journal.pone.0083481"},{"issue":"11-12","key":"2020050721285052000_67.5.963.83","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/apt.13816","article-title":"Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis","volume":"44","author":"Harrison","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721285052000_67.5.963.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2008.04.003"},{"key":"2020050721285052000_67.5.963.85","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and\u00a0-\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"2020050721285052000_67.5.963.86","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26081"},{"key":"2020050721285052000_67.5.963.87","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2017-315691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T03:59:45Z","timestamp":1660363185000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2017-315691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":87,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,6]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/gutjnl-2017-315691"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2017-315691","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,24]]}}}